Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Angela Christiano
Columbia University Health Sciences, Department: Dermatology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Aclaris Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Christiano is a consultant to, and owns stock in, Aclaris Therapeutics. Aclaris has licensed intellectual property from Columbia arising from work in Dr. Christiano’s Columbia lab, but it does not appear that the company’s current efforts involve development of the Columbia technology. Dr. Christiano has disclosed several projects that occurred over the past year that relate to other Aclaris technology, including studies relating to mouse chow, JAK2 inhibitors, and to an Aclaris topical compound. In addition, further work relating to Aclaris is planned for future years of the grant. Given Dr. Christiano’s significant financial interests in the company, Columbia has determined that the outcome of this research could affect the company and her financial interests in Aclaris, and that the design, conduct, and/or reporting of this research could be affected by her interests in Aclaris.
Alopecia Areata Center for Research Translation (AACORT)
Overall AACORT Narrative The Alopecia Areata Center of Research Translation (AACORT) at Columbia University Medical Center (CUMC) is focused on the singular goal of developing new treatments for alopecia areata (AA). In the past few years, the AACORT team has made transformative progress in understanding the pathogenesis AA, as well as initiating a series of clinical trials aimed at reversing the disease. The goal of this AACORT is to build upon our established translational pipeline to leverage our basic and preclinical discoveries into the clinical setting.
Filed on February 05, 2019.
Tell us what you know about Angela Christiano's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Angela Christiano filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Angela Christiano | Columbia University Health Sciences | Conflict of Interest | Aclaris Therapeutics | $350,000 - $399,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.